Molecular Subtypes of Clear Cell Renal Cell Carcinoma Are Associated with Sunitinib Response in the Metastatic Setting

被引:266
作者
Beuselinck, Benoit [1 ,2 ,3 ,5 ]
Job, Sylvie [6 ]
Becht, Etienne [2 ,4 ]
Karadimou, Alexandra [1 ,2 ,3 ]
Verkarre, Virginie [2 ,7 ]
Couchy, Gabrielle [1 ,2 ,3 ]
Giraldo, Nicolas [2 ,4 ]
Rioux-Leclercq, Nathalie [8 ]
Molinie, Vincent [9 ]
Sibony, Mathilde [2 ,10 ]
Elaidi, Reza [5 ]
Teghom, Corinne [5 ]
Patard, Jean-Jacques [11 ]
Mejean, Arnaud [2 ,5 ]
Fridman, Wolf Herman [2 ,3 ,4 ]
Sautes-Fridman, Catherine [2 ,3 ,4 ]
de Reynies, Aurelien [6 ]
Oudard, Stephane [2 ,5 ]
Zucman-Rossi, Jessica [1 ,2 ,3 ,5 ]
机构
[1] INSERM, UMR 1162, Genom Fonct Tumeurs Solides, F-75010 Paris, France
[2] Univ Paris 05, Sorbonne Paris Cite, Fac Med, Paris, France
[3] Labex Immuno oncol, Paris, France
[4] Ctr Rech Cordeliers, UMR S1138, Paris, France
[5] Hop Europeen Georges Pompidou, AP HP, Dept Oncol, Paris, France
[6] Ligue Natl Canc, Programme Cartes Ident Tumeurs, Paris, France
[7] Hop Necker Enfants Malad, AP HP, Dept Pathol, Paris, France
[8] CHU Rennes, Dept Pathol, Rennes, France
[9] Clin St Joseph, Dept Pathol, Paris, France
[10] Hop Cochin, AP HP, Dept Pathol, F-75674 Paris, France
[11] Hop Bicetre, Dept Urol, Le Kremlin Bicetre, France
关键词
C-REACTIVE PROTEIN; INTERFERON-ALPHA; TARGETED THERAPY; POOR SURVIVAL; CANCER; EXPRESSION; DYNAMICS; DEFINES; GAP;
D O I
10.1158/1078-0432.CCR-14-1128
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
Purpose: Selecting patients with metastatic clear-cell renal cell carcinoma (m-ccRCC) who might benefit from treatment with targeted tyrosine kinase inhibitors (TKI) is a challenge. Our aim was to identify molecular markers associated with outcome in patients with m-ccRCC treated with sunitinib. Experimental Design: We performed global transcriptome analyses on 53 primary resected ccRCC tumors from patients who developed metastatic disease and were treated with first-line sunitinib. We also determined chromosome copy-number aberrations, methylation status, and gene mutations in von Hippel-Lindau and PBRM1. Molecular data were analyzed in relation with response rate (RR), progression-free survival (PFS), and overall survival (OS). Validation was performed in 47 additional ccRCC samples treated in first-line metastatic setting with sunitinib. Results: Unsupervised transcriptome analysis identified 4 robust ccRCC subtypes (ccrcc1 to 4) related to previous molecular classifications that were associated with different responses to sunitinib treatment. ccrcc1/ccrcc4 tumors had a lower RR (P = 0.005) and a shorter PFS and OS than ccrcc2/ccrcc3 tumors (P = 0.001 and 0.0003, respectively). These subtypes were the only significant covariate in the multivariate Cox model for PFS and OS (P = 0.017 and 0.006, respectively). ccrcc1/ccrcc4 tumors were characterized by a stem-cell polycomb signature and CpG hypermethylation, whereas ccrcc3 tumors, sensitive to sunitinib, did not exhibit cellular response to hypoxia. Moreover, ccrcc4 tumors exhibited sarcomatoid differentiation with a strong inflammatory, Th1-oriented but suppressive immune microenvironment, with high expression of PDCD1 (PD-1) and its ligands. Conclusions: ccRCC molecular subtypes are predictive of sunitinib response in metastatic patients, and could be used for personalized mRCC treatment with TKIs, demethylating or immunomodulatory drugs. (C)2015 AACR.
引用
收藏
页码:1329 / 1339
页数:11
相关论文
共 40 条
[1]
A Decrease of Regulatory T Cells Correlates With Overall Survival After Sunitinib-based Antiangiogenic Therapy in Metastatic Renal Cancer Patients [J].
Adotevi, Olivier ;
Pere, Helene ;
Ravel, Patrice ;
Haicheur, Nacilla ;
Badoual, Cecile ;
Merillon, Nathalie ;
Medioni, Jacques ;
Peyrard, Severine ;
Roncelin, Stephane ;
Verkarre, Virginie ;
Mejean, Arnaud ;
Fridman, Wolf H. ;
Oudard, Stephane ;
Tartour, Eric .
JOURNAL OF IMMUNOTHERAPY, 2010, 33 (09) :991-998
[2]
Chromatin dynamics during cellular reprogramming [J].
Apostolou, Effie ;
Hochedlinger, Konrad .
NATURE, 2013, 502 (7472) :462-471
[3]
Assessing the significance of chromosomal aberrations in cancer: Methodology and application to glioma [J].
Beroukhim, Rameen ;
Getz, Gad ;
Nghiemphu, Leia ;
Barretina, Jordi ;
Hsueh, Teli ;
Linhart, David ;
Vivanco, Igor ;
Lee, Jeffrey C. ;
Huang, Julie H. ;
Alexander, Sethu ;
Du, Jinyan ;
Kau, Tweeny ;
Thomas, Roman K. ;
Shah, Kinial ;
Soto, Horacio ;
Perner, Sven ;
Prensner, John ;
Debiasi, Ralph M. ;
Demichelis, Francesca ;
Hatton, Charlie ;
Rubin, Mark A. ;
Garraway, Levi A. ;
Nelson, Stan F. ;
Liau, Linda ;
Mischel, Paul S. ;
Cloughesy, Tim F. ;
Meyerson, Matthew ;
Golub, Todd A. ;
Lander, Eric S. ;
Mellinghoff, Ingo K. ;
Sellers, William R. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2007, 104 (50) :20007-20012
[4]
Prognostic impact of baseline serum C-reactive protein in patients with metastatic renal cell carcinoma (RCC) treated with sunitinib [J].
Beuselinck, Benoit ;
Vano, Yann-Alexandre ;
Oudard, Stephane ;
Wolter, Pascal ;
De Smet, Robert ;
Depoorter, Lore ;
Teghom, Corine ;
Karadimou, Alexandra ;
Zucman-Rossi, Jessica ;
Debruyne, Philip R. ;
Van Poppel, Hendrik ;
Joniau, Steven ;
Lerut, Evelyne ;
Strijbos, Michiel ;
Dumez, Herlinde ;
Paridaens, Robert ;
Van Calster, Ben ;
Schoffski, Patrick .
BJU INTERNATIONAL, 2014, 114 (01) :81-89
[5]
Spatiotemporal Dynamics of Intratumoral Immune Cells Reveal the Immune Landscape in Human Cancer [J].
Bindea, Gabriela ;
Mlecnik, Bernhard ;
Tosolini, Marie ;
Kirilovsky, Amos ;
Waldner, Maximilian ;
Obenauf, Anna C. ;
Angell, Helen ;
Fredriksen, Tessa ;
Lafontaine, Lucie ;
Berger, Anne ;
Bruneval, Patrick ;
Fridman, Wolf Herman ;
Becker, Christoph ;
Pages, Franck ;
Speicher, Michael R. ;
Trajanoski, Zlatko ;
Galon, Jerome .
IMMUNITY, 2013, 39 (04) :782-795
[6]
Mutational characterization of individual breast tumors: TP53 and PI3K pathway genes are frequently and distinctively mutated in different subtypes [J].
Boyault, Sandrine ;
Drouet, Youenn ;
Navarro, Claudine ;
Bachelot, Thomas ;
Lasset, Christine ;
Treilleux, Isabelle ;
Tabone, Eric ;
Puisieux, Alain ;
Wang, Qing .
BREAST CANCER RESEARCH AND TREATMENT, 2012, 132 (01) :29-39
[7]
Meta-analysis of Clear Cell Renal Cell Carcinoma Gene Expression Defines a Variant Subgroup and Identifies Gender Influences on Tumor Biology [J].
Brannon, A. Rose ;
Haake, Scott M. ;
Hacker, Kathryn E. ;
Pruthi, Raj S. ;
Wallen, Eric M. ;
Nielsen, Matthew E. ;
Rathmell, W. Kimryn .
EUROPEAN UROLOGY, 2012, 61 (02) :258-268
[8]
Brannon A Rose, 2010, Genes Cancer, V1, P152
[9]
von Hippel-Lindau gene status and response to vascular endothelial growth factor targeted therapy for metastatic clear cell renal cell carcinoma [J].
Choueiri, Toni K. ;
Vaziri, Susan A. J. ;
Jaeger, Erich ;
Elson, Paul ;
Wood, Laura ;
Bhalla, Ish Prasad ;
Small, Eric J. ;
Weinberg, Vivian ;
Sein, Nancy ;
Simko, Jeff ;
Golshayan, Ali-Reza ;
Sercia, Linda ;
Zhou, Ming ;
Waldman, Frederic M. ;
Rini, Brian I. ;
Bukowski, Ronald M. ;
Ganapathi, Ram .
JOURNAL OF UROLOGY, 2008, 180 (03) :860-865
[10]
Comprehensivemolecular characterization of clear cell renal cell carcinoma [J].
Creighton, Chad J. ;
Morgan, Margaret ;
Gunaratne, Preethi H. ;
Wheeler, David A. ;
Gibbs, Richard A. ;
Robertson, A. Gordon ;
Chu, Andy ;
Beroukhim, Rameen ;
Cibulskis, Kristian ;
Signoretti, Sabina ;
Vandin, Fabio ;
Wu, Hsin-Ta ;
Raphael, Benjamin J. ;
Verhaak, Roel G. W. ;
Tamboli, Pheroze ;
Torres-Garcia, Wandaliz ;
Akbani, Rehan ;
Weinstein, John N. ;
Reuter, Victor ;
Hsieh, James J. ;
Brannon, A. Rose ;
Hakimi, A. Ari ;
Jacobsen, Anders ;
Ciriello, Giovanni ;
Reva, Boris ;
Ricketts, Christopher J. ;
Linehan, W. Marston ;
Stuart, Joshua M. ;
Rathmell, W. Kimryn ;
Shen, Hui ;
Laird, Peter W. ;
Muzny, Donna ;
Davis, Caleb ;
Morgan, Margaret ;
Xi, Liu ;
Chang, Kyle ;
Kakkar, Nipun ;
Trevino, Lisa R. ;
Benton, Susan ;
Reid, Jeffrey G. ;
Morton, Donna ;
Doddapaneni, Harsha ;
Han, Yi ;
Lewis, Lora ;
Dinh, Huyen ;
Kovar, Christie ;
Zhu, Yiming ;
Santibanez, Jireh ;
Wang, Min ;
Hale, Walker .
NATURE, 2013, 499 (7456) :43-+